Bicara Therapeutics Inc. Common Stock
BCAX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Assets | – | – | – |
| Cash & Equivalents | $490 | $230 | $4 |
| Short-Term Investments | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Curr. Assets | $13 | $1 | $1 |
| Total Curr. Assets | $503 | $231 | $5 |
| Property Plant & Equip (Net) | $1 | $1 | $1 |
| Goodwill | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 |
| Tax Assets | $59 | $0 | $0 |
| Other NC Assets | $7 | $2 | $1 |
| Total NC Assets | $67 | $3 | $2 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $569 | $234 | $7 |
| Liabilities | – | – | – |
| Payables | $5 | $3 | $5 |
| Short-Term Debt | $1 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 |
| Other Curr. Liab. | $13 | $12 | $19 |
| Total Curr. Liab. | $18 | $15 | $24 |
| LT Debt | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $59 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 |
| Total NC Liab. | $59 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 |
| Cap. Leases | $0 | $1 | $0 |
| Total Liabilities | $77 | $15 | $24 |
| Equity | – | – | – |
| Pref Stock | $0 | $367 | $82 |
| Common Stock | $0 | $0 | $0 |
| Retained Earnings | -$221 | -$153 | -$101 |
| AOCI | $0 | -$0 | $0 |
| Other Equity | $713 | $4 | $2 |
| Total Equity | $492 | $219 | -$17 |
| Supplemental Information | – | – | – |
| Minority Interest | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $569 | $234 | $7 |
| Net Debt | -$489 | -$230 | -$4 |